Real-World Clinical Experience of Oral Semaglutide in a Secondary Diabetes Clinic in the UK: A Retrospective Observational Study.

David M WilliamsBarbara-Alex AlbertsAsem SharafGiselle SharafStephen C BainAtul KalhanThinzar Min

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

Oral semaglutide was effective in improving cardiovascular risk factors in this real-world population living with T2D, and no serious events were identified related to oral semaglutide in this patient group.

Keyphrases

cardiovascular risk factors
cardiovascular disease
type diabetes
primary care
case report
cross sectional
weight loss
drug induced